News & Publications

Industry News

Mar
16

Southeastern Wound Healing Center received awards for excellence

Southeastern Wound Healing Center has received two awards for excellence.

The center, an affiliate of Southeastern Health, has been honored with the 2017 Center of Distinction Award and the 2017 Robert A. Warriner III, M.D., Center of Excellence award, which were given to the center by Healogics, the nation’s largest provider of advanced wound care services.

Read More
Mar
16

Wound Care Center wins award

The Wound Care Center and Hyperbaric Services at Upper Valley Medical Center (UVMC) has been recognized with a national award for clinical and operational excellence. The 2017 Robert A. Warriner III Center of Excellence Award was presented by Healogics, the world’s largest wound care management company.

Read More
Mar
7

Call to empower care staff in monitoring skin integrity

The usual strategy in aged care is to have care workers provide the basics, such as showering or assisting with meals, but they have a key role to play in wound prevention, said Hayley Puckeridge, Uniting wound clinical nurse consultant. She called on aged care organizations to empower their care staff because they are critical to observing skin integrity issues as they saw residents at their most vulnerable including when naked.

Read More
Mar
6

RenovoDerm Receives FDA Clearance for Proprietary Product

Today, RenovoDerm, a wound care device company, announced that the U.S. Food and Drug Administration (FDA) has cleared its proprietary product, the Phoenix Wound MatrixTM, which is a wound care device that accelerates the body’s healing response, facilitates tissue growth and regeneration, reduces scar formation and enhances overall cosmesis.

Read More
Mar
6

Cardiovascular Systems Presents LIBERTY 360° 18-Month Outcomes at CRT18 Interventional Cardiology Conference

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, presented 18-month outcomes from its LIBERTY 360° study at the Cardiovascular Research Technologies (CRT) 2018 interventional cardiology conference in Washington, D.C.

Read More